Nutraceuticals and Functional Foods in the Management of Hyperlipidemia
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Hyperlipidemia is one of the major risk factor for the development of cardiovascular disease. Hypolipidemic nutraceuticals and functional foods help improve serum lipid profiles as reducing total cholesterol, triglyceride, and low-density lipoprotein cholesterol, while elevating high-density lipoprotein cholesterol. The effectiveness of omega-3 polyunsaturated fatty acid, phytosterols, dietary fiber, and tea catechin in management of hyperlipidemia has been clearly demonstrated in epidemiological and interventional trials. Studies on mechanism reveal that they act as inhibitor or activator of critical enzyme, agonist or inhibitor of transcription factor, competitor of transporter, and sequestrant of bile acid to modulate lipid homeostasis. Hypolipidemic effects are also claimed in dietary proteins, many polyphenols, other phytochemicals, raw extract, or even whole food. This review attempts to give an overview of lipid homeostasis and summarize recent findings of hypolipidemic nutraceuticals and functional foods according to their active ingredients, focusing on the efficacy and underlying mechanisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Polyphenols: Food sources and bioavailability
Manach, C., Scalbert, A., Morand, C., Rémésy, C., & Jiménez, L. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/79.5.727 · Cited by 8,175
Health benefits of dietary fiber
Anderson, J. W., Baird, P., Davis Jr, R. H., Ferreri, S., Knudtson, M., Koraym, A., Waters, V., & Williams, C. L. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.2009.00189.x · Cited by 2,239
Forman, B. M., Chen, J., & Evans, R. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4312 · Cited by 2,116
Nuclear Receptors and Lipid Physiology: Opening the X-Files
Chawla, A., Repa, J. J., Evans, R. M., & Mangelsdorf, D. J. (2001) · Science · doi:10.1126/science.294.5548.1866 · Cited by 2,085
Molecular mediators of hepatic steatosis and liver injury
Browning, J. D., & Horton, J. D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422422 · Cited by 1,772
Regulation of Muscle Fiber Type and Running Endurance by PPARδ
Wang, Y.-X., Zhang, C.-L., Yu, R. T., Cho, H. K., Nelson, M. C., Bayuga-Ocampo, C. R., Ham, J., Kang, H., & Evans, R. M. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020294 · Cited by 1,089
MicroRNA-33 and the SREBP Host Genes Cooperate to Control Cholesterol Homeostasis
Najafi-Shoushtari, S. H., Kristo, F., Li, Y., Shioda, T., Cohen, D. E., Gerszten, R. E., & Näär, A. M. (2010) · Science · doi:10.1126/science.1189123 · Cited by 957
LXR Regulates Cholesterol Uptake Through Idol-Dependent Ubiquitination of the LDL Receptor
Zelcer, N., Hong, C., Boyadjian, R., & Tontonoz, P. (2009) · Science · doi:10.1126/science.1168974 · Cited by 848
LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes
Laffitte, B. A., Repa, J. J., Joseph, S. B., Wilpitz, D. C., Kast, H. R., Mangelsdorf, D. J., & Tontonoz, P. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.2.507 · Cited by 683 · cited 1×
“In macrophage, several proteins involved in reverse cholesterol transport were identified as direct LXRs target genes, including ABCA1, ABCG1, ABCG4 and apoE (Kennedy et al., 2001; Laffitte et al., 2001; Wagner et al., 2003).”
BackgroundHypertriglyceridemia: its etiology, effects and treatment
Yuan, G., Al-Shali, K. Z., & Hegele, R. A. (2007) · Canadian Medical Association Journal · doi:10.1503/cmaj.060963 · Cited by 624 · cited 3×
“Severe hypertriglyceridemia is also a risk factor for pancreatitis (Yuan et al., 2007) and excessive TGs accumulated in the liver will give rise to fatty liver disease (nonalcoholic steatohepatitis) (Ferre and Foufelle, 2010).”
Background
Cited by
A Comprehensive Review on Nutraceuticals: Therapy Support and Formulation Challenges
Puri, V., Nagpal, M., Singh, I., Singh, M., Dhingra, G. A., Huanbutta, K., Dheer, D., Sharma, A., & Sangnim, T. (2022) · Nutrients · doi:10.3390/nu14214637 · Cited by 348
McClements, D. J. (2015) · Journal of Food Science · doi:10.1111/1750-3841.12919 · Cited by 328
Cyclodextrins in Food Technology and Human Nutrition: Benefits and Limitations
Fenyvesi, É., Vikmon, M., & Szente, L. (2016) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2013.809513 · Cited by 223
(-)-Epicatechin regulates blood lipids and attenuates hepatic steatosis in rats fed high-fat diet
Cheng, H., Xu, N., Zhao, W., Su, J., Liang, M., Xie, Z., Wu, X., & Li, Q. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201700303 · Cited by 81
Cicero, A. F. G., Fogacci, F., Rosticci, M., Parini, A., Giovannini, M., Veronesi, M., D’Addato, S., & Borghi, C. (2017) · Nutrition & Metabolism · doi:10.1186/s12986-017-0214-2 · Cited by 41
“Abbreviation ApoAI: Apolipoprotein AI; ApoB: Apolipoprotein B100; CPK: Creatinin-PhosfoKinase; HDL-C: High-density lipoprotein-cholesterol; LDL-C: LDL-Cholesterol; TC: Total cholesterol; TG: Triglycerides Acknowledgements Not applicable.”
BackgroundInfluential
Metadata
- Authors
- Chen, G., Wang, H., Zhang, X., & Yang, S.-T.
- Venue
- Critical Reviews in Food Science and Nutrition
- Publisher
- Informa UK Limited
- Published
- 2014-01
- Volume
- 54
- Issue
- 9
- Pages
- 1180-1201
- ISSN
- 1040-8398 (ISSN-L)
- 1549-7852
- OpenAlex
- W2016837411
- Cited by
- 120
- References
- 20
- FWCI
- 11.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Nutraceuticals and Functional Foods in the Management of Hyperlipidemia. https://app.cochat.ai/papers/10.1080/10408398.2011.629354
- The paper
- Chen, G., Wang, H., Zhang, X., & Yang, S.-T. (2014). Nutraceuticals and Functional Foods in the Management of Hyperlipidemia. Critical Reviews in Food Science and Nutrition. https://doi.org/10.1080/10408398.2011.629354
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.